Zdrowie i gospodarka · 29.08.2003
Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Human Pharmaceutical Applications and Related Submissions; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Providing Regulatory Submissions in Electronic Format--Human Pharmaceutical Product Applications and Related Submissions." This is one in a series of guidance documents on providing regulatory submissions to FDA in electronic format. This guidance discusses issues related to the electronic submission of new drug applications (NDAs), abbreviated new drug applications (ANDAs), biologics licensing applications (BLAs), investigational new drug applications (INDs), master files, advertising material, and promotional labeling. The submission of these documents in electronic format should improve the agency's efficiency in processing, archiving, and reviewing them.